Zoledronic acid: summary review and side effects profile published on the NPS RADAR

An excerpt of the summary review and side effects profile of Zoledronic acid, published on the australian NPS RADAR: Zoledronic acid is an intravenous bisphosphonate. It is given as a once-yearly infusion for osteoporosis in women with any fracture, and in men with a minimal-trauma hip fracture. Some patients may prefer zoledronic acid to oral […]

Atrial fibrillation and bisphosphonates: FDA Medwatch update

FDA issued an update to the Agency’s review of safety data regarding the potential increased risk of atrial fibrillation in patients treated with a bisphosphonate drug. Bisphosphonates marketed as Alendronate (Fosamax, Fosamax Plus D) Etidronate (Didronel) Ibandronate (Boniva) Pamidronate (Aredia) Risedronate (Actonel, Actonel W/Calcium) Tiludronate (Skelid) Zoledronic acid (Reclast, Zometa) Bisphosphonates are a class of […]